Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models
Open Access
- 30 May 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 818696
Abstract
Brain tumors are a large and heterogeneous group of neoplasms that affect the central nervous system and include some of the deadliest cancers. Almost all the conventional and new treatments fail to hinder tumoral growth of the most malignant brain tumors. This is due to multiple factors, such as intra-tumor heterogeneity, the microenvironmental properties of the human brain, and the lack of reliable models to test new therapies. Therefore, creating faithful models for each tumor and discovering tailored treatments pose great challenges in the fight against brain cancer. Over the years, different types of models have been generated, and, in this review, we investigated the advantages and disadvantages of the models currently used.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro
This publication has 182 references indexed in Scilit:
- A Novel Zebrafish Xenotransplantation Model for Study of Glioma Stem Cell InvasionPLOS ONE, 2013
- Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYCCancer Cell, 2012
- A Mouse Model of the Most Aggressive Subgroup of Human MedulloblastomaCancer Cell, 2012
- An Animal Model of MYC-Driven MedulloblastomaCancer Cell, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Malignant Astrocytomas Originate from Neural Stem/Progenitor Cells in a Somatic Tumor Suppressor Mouse ModelCancer Cell, 2009
- GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null backgroundGlia, 2008
- Acquisition of Granule Neuron Precursor Identity Is a Critical Determinant of Progenitor Cell Competence to Form Shh-Induced MedulloblastomaCancer Cell, 2008
- Medulloblastoma Can Be Initiated by Deletion of Patched in Lineage-Restricted Progenitors or Stem CellsCancer Cell, 2008